
Goutham Sunny
@medoncodoc
Academic account. Oncology & #medtwitter. Passionate about Preventive & community oncology, Big data, Computational onco and AI, Health economics, Med-Ed.
ID: 99938573
28-12-2009 12:37:39
2,2K Tweet
424 Takipçi
597 Takip Edilen

Beamion LUNG 1 - Zongertinib in previously treated Her2 mutated NSCLC. Phase 1 data, 71% ORR, DoR 14.1m, mPFS 12.4m. Good safety profile. Promising data. DOI: 10.1056/NEJMoa2503704 Dr Amol Akhade Dr Akhil Santhosh Narjust Florez, MD, FASCO OncoAlert
